跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,751 条关于
“EGFRm”
全部
1,751
临床试验
1,366
药物
148
机构
0
资讯
237
去年
Evolving Treatment Landscape for EGFR-Mutant NSCLC: Managing Resistance and Optimizing Therapy Sequence
去年
Black Diamond Therapeutics Announces Phase 2 Data for BDTX-1535 in Recurrent EGFRm NSCLC
去年
TAGRISSO and ORPATHYS Combination Shows Promise in MET-Driven EGFR-Mutated NSCLC
去年
EU Recommends Approval of AstraZeneca's Tagrisso for Unresectable EGFR-Mutated NSCLC
6个月前
Black Diamond Therapeutics Reports Promising Phase 2 Data for Silevertinib in EGFR-Mutant Cancers
4年前
Tagrisso Plus Savolitinib Shows Promising 49% Response Rate in EGFR-Mutated Lung Cancer with MET Resistance
去年
HUTCHMED Presents Clinical Data for Multiple Cancer Therapies at Major Oncology Conferences
去年
Savolitinib Plus TAGRISSO® Shows 56% Response Rate in MET-High Lung Cancer, HUTCHMED Reports
去年
DualityBio's HER3-Targeting ADC DB-1310 Receives FDA Fast Track Designation for EGFR-Mutant Lung Cancer
去年
AstraZeneca's Oncology Innovations and Financial Growth Prospects
第 1 页,共 24 页
上一页
下一页